| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $7.4B | $6.9B | — | — | — | — | — | — |
| Cost of Revenue | $4.7B | $4.5B | $4.2B | $4.0B | $3.6B | $3.0B | $3.4B | $3.2B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B | $0.1B |
| SG&A Expense | $0.8B | $0.7B | $0.7B | $0.6B | $0.6B | $0.5B | $0.6B | $0.6B |
| Operating Income | $1.9B | $1.8B | $1.7B | $1.5B | $1.3B | $1.0B | $0.3B | $0.3B |
| Net Income | $1.5B | $1.4B | $1.3B | $1.2B | $1.0B | $0.9B | $0.2B | $0.2B |
| EPS (Basic) | $6.42 | $5.95 | $5.70 | $5.04 | $4.29 | $3.80 | $0.97 | $0.92 |
| EPS (Diluted) | $6.40 | $5.93 | $5.67 | $5.01 | $4.25 | $3.77 | $0.96 | $0.91 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $16.1B | $14.6B | $15.0B | $12.4B | $11.9B | $10.4B | $9.8B | $8.7B |
| Current Assets | $3.0B | $2.6B | $2.8B | $2.5B | $2.1B | $2.5B | $2.0B | $1.8B |
| Cash & Equivalents | $0.5B | $0.4B | $0.4B | $0.3B | $0.3B | $1.2B | $0.4B | $0.4B |
| Total Liabilities | $5.4B | $5.0B | $6.3B | $5.0B | $5.0B | $4.4B | $4.7B | $4.4B |
| Current Liabilities | $2.8B | $2.1B | $2.9B | $1.6B | $1.6B | $1.1B | $1.4B | $1.3B |
| Stockholders' Equity | $10.6B | $9.7B | $8.7B | $7.5B | $6.9B | $5.9B | $5.1B | $4.2B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.8B | $1.8B | $1.7B | $1.1B | $1.2B | $1.3B | $1.1B | $0.9B |
| Investing Cash Flow | $-1.1B | $-0.2B | $-2.4B | $-0.6B | $-2.1B | $0.1B | $-1.2B | $-1.2B |
| Capital Expenditures | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| Financing Cash Flow | $-0.7B | $-1.6B | $0.7B | $-0.6B | $0.0B | $-0.5B | $0.1B | $0.0B |